Log In
Print this Print this

BCN 002

  Manage Alerts
Collapse Summary General Information
Company Boryung Pharmaceutical Co. Ltd.
DescriptionKinase inhibitor
Molecular Target
Mechanism of ActionKinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today